Those who have received a diagnosis of type 1 diabetes, experienced a decrease in weight of more than 11 pounds 90 days before screening, have a family or personal history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Syndrome Type 2, have taken or intend to start taking weight loss supplements, prescriptions, or over-the-counter medications within 90 days before screening, are Tanner stage 1 prepubertal, have a history of chronic or acute pancreatitis, or have undergone/plan to undergo weight reduction procedures are not eligible to participate
Next, we further investigated the molecular mechanisms involved in the regulation of CBS activity using a combined genetic and drug screening approach
This benefit supports enhanced satiety, blood sugar support, and improved digestion
CBSNews.com, Jan 11, 2024